MHRA Class 2 Medicines Recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)
MHRA Class 2 Medicines Recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)
February 17, 2021
Class 2 Medicines recall: MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited)
Drug alert number: EL (21) A/04
Date issued: 16th February 2021
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall for:
MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution (Eastone Limited) MS 3297
Eaststone Limited has informed MHRA of an issue related to underfilled or empty bottles for MidaBuc – Midazolam (as HCL) 10mg/mL Oromucosal Solution. The below batch is being recalled.
| Batch Number | Expiry Date | Pack Size | First Distributed |
| ES84553 | 15 April 2021 | 5ml | 26 April 2019 |
Advice for healthcare professionals
Stop supplying the above batches immediately. Quarantine all remaining stock and return it to your supplier using your supplier’s approved process.
Full drug alert can be viewed here.
Company contacts for further information
For more information or medical information queries contact Eaststone at specials@eaststone.co.uk or alternatively call 0800 678 3102.
Posted in: Contract & IT, Dispensing & Supply
